How US FDA Will Unleash Attack On COVID-19 Variants Once Global Consensus Is Reached

Agency outlines plans to authorize variant COVID-19 vaccines and therapeutics based on swift quality assessments.

Immunological system, antibodies attacking the virus covid-19. 3D illustration, concept of the body's defense system. Y-shaped antibody attacking the coronavirus.
planning for takedown of COVID-19 variants

Streamlined quality assessments of new and improved vaccines and therapeutics for emerging variants of the SARS-CoV-2 virus outlined in 22 February US Food and Drug Administration guidance should expedite authorization once there is international agreement on when to use them.

Of particular concern is the B.1.351 variant seen first in South Africa because studies suggest it reduces efficacy of vaccines...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Manufacturing

More from Compliance